ID: ALA3087953

Max Phase: Preclinical

Molecular Formula: C29H36N3O3+

Molecular Weight: 474.63

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O[C@H]1C[N+]2(Cc3nc(-c4ccccc4)no3)CCC1CC2)C1(C2=CC=CC2)CCCCCC1

Standard InChI:  InChI=1S/C29H36N3O3/c33-28(29(24-12-6-7-13-24)16-8-1-2-9-17-29)34-25-20-32(18-14-22(25)15-19-32)21-26-30-27(31-35-26)23-10-4-3-5-11-23/h3-7,10-12,22,25H,1-2,8-9,13-21H2/q+1/t22?,25-,32?/m0/s1

Standard InChI Key:  HSIJWKXHMVAASP-LAAOYOPBSA-N

Associated Targets(Human)

Liver microsome 8277 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Muscarinic acetylcholine receptor M3 7750 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cavia porcellus 23802 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Muscarinic acetylcholine receptor M3 1154 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 474.63Molecular Weight (Monoisotopic): 474.2751AlogP: 5.62#Rotatable Bonds: 6
Polar Surface Area: 65.22Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 1.44CX LogD: 1.44
Aromatic Rings: 2Heavy Atoms: 35QED Weighted: 0.31Np Likeness Score: 0.01

References

1. Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V..  (2013)  The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.,  23  (23): [PMID:24144851] [10.1016/j.bmcl.2013.09.092]

Source